Front-line therapy in lung cancer with mutations in EGFR

Lorenza Landi, Federico Cappuzzo
  • Nature Reviews Clinical Oncology, August 2011, Springer Science + Business Media
  • DOI: 10.1038/nrclinonc.2011.135

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1038/nrclinonc.2011.135

The following have contributed to this page: Dr Federico Cappuzzo

In partnership with: